Based on recent data, Pacira BioSciences, Inc. (PCRX) shows an Average True Range (ATR) of 0.91 and an Enterprise Value of 1.64B. Its average trading volume over the past 3 months is 492.34K, indicating liquidity. These fundamental metrics provide insight into PCRX's underlying financial health and market activity.
| ATR | 0.91 |
| Enterprise Value | 1.64B |
| Avg Vol (3 Months) | 492.34K |
| Avg Vol (10 Days) | 575.5K |
Pacira BioSciences, Inc. (PCRX) technical indicators as of June 26, 2026: the SMA 20 is 3.41%, SMA 50 at -1.74%, and SMA 200 at -5.58%. The RSI 14 value is 52.66, suggesting its current momentum. These technical analysis signals help assess PCRX's price trends and potential future movements.
| SMA 20 | 3.41% |
| SMA 50 | -1.74% |
| SMA 200 | -5.58% |
| RSI 14 | 52.66 |
Pacira BioSciences, Inc. (PCRX) stock performance overview as of June 26, 2026: The 52-week high is $27.64 (currently -18.27% below), and the 52-week low is $18.8 (currently 20.16% above). Over the past year, PCRX's performance is -12.51%, compared to the S&P 500's 8.41% change.
| 52-Week High | 27.64 |
| 52-Week High Chg | -18.27% |
| 52-Week Low | 18.8 |
| 52-Week Low Chg | +20.16% |
| S&P 500 52-Week Chg | 8.41% |
According to market data, Pacira BioSciences, Inc. (PCRX) stock's recent performance metrics show that over the last month, PCRX is -27.31%, with a Year-to-Date (YTD) performance of -25.43%. Over the past year, the stock has seen a -12.51% change. These figures summarize PCRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 24.49 | 25.17 | 26.27 | 27.16 | 27.64 | 26.81 |
| Low | 22 | 22 | 21.84 | 18.8 | 18.8 | 18.8 |
| Performance | -15.83% | -27.31% | -15.61% | -12.95% | -12.51% | -25.43% |
According to current financial data, PCRX stock's P/E (TTM) ratio is 197.55, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for PCRX, including P/S (1.29), P/B (1.49), and P/FCF (7.15), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | PCRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 197.55 | -1.22 | 12.85 | 32.59 |
| P/S (TTM) | 1.29 | 3.69 | 6.17 | 5.98 |
| P/B (TTM) | 1.49 | 1.67 | 26.46 | 5.43 |
| P/FCF (TTM) | 7.15 | 0 | 3.99 | 30.72 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep